Sectors
TXMD
TherapeuticsMD, Inc.
2.23
1 x 1.90
1 x 2.58
bid
ask
+
0.01
0.64%
01:29 PM
timesize
| Ytd | 37.07% | |
| 1y | 101.29% |
2.17
day range
2.28
0.99
52 week range
2.95
| Open | 2.17 | Prev Close | 2.22 | Low | 2.17 | High | 2.28 | Mkt Cap | 25.86M |
| Vol | 38.15K | Avg Vol | 42.08K | EPS | -0.03 | P/E | N/A | Forward P/E | 3.13 |
| Beta | 0.61 | Short Ratio | 0.95 | Inst. Own | 44.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.06 | 200-d Avg | 2.05 | 1yr Est | 5.00 |
| Income Statement | |||
| Total Revenue | 869.00K | ||
| Revenues (USD) | 869.00K | ||
| Gross Profit | 869.00K | ||
| Operating Expenses | 1.69M | ||
| Selling, General and Administrative Expense | 1.58M | ||
| Operating Income | -816.00K | ||
| Net Income | 155.00K | ||
| Net Income Common Stock | 155.00K | ||
| Net Income Common Stock (USD) | 155.00K | ||
| Consolidated Income | 155.00K | ||
| Net Income from Discontinued Operations | 9.00K | ||
| Earnings per Basic Share | 0.01 | ||
| Earnings per Basic Share (USD) | 0.01 | ||
| Earnings per Diluted Share | 0.01 | ||
| Earning Before Interest & Taxes (EBIT) | 155.00K | ||
| Earning Before Interest & Taxes (USD) | 155.00K | ||
| Weighted Average Shares | 11.57M | ||
| Weighted Average Shares Diluted | 11.64M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.19M | ||
| Cash and Equivalents (USD) | 9.19M | ||
| Trade and Non-Trade Receivables | 3.39M | ||
| Current Assets | 16.12M | ||
| Property, Plant & Equipment Net | 4.83M | ||
| Total Assets | 37.53M | ||
| Total Debt | 4.52M | ||
| Current Liabilities | 5.00M | ||
| Debt Non-Current | 4.52M | ||
| Total Liabilities | 10.40M | ||
| Accumulated Retained Earnings (Deficit) | -952.14M | ||
| Shareholders Equity | 27.13M | ||
| Shareholders Equity (USD) | 27.13M | ||
| Assets Non-Current | 21.41M | ||
| Total Debt (USD) | 4.52M | ||
| Goodwill and Intangible Assets | 3.56M | ||
| Liabilities Non-Current | 5.39M | ||
| Trade and Non-Trade Payables | 460.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 329.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 770.00K | ||
| Net Cash Flow from Operations | -9.00K | ||
| Share Based Compensation | 4.00K | ||